drugset / Trial / NCT00346970

The High Density Lipoprotein and Endothelial Function, Niacin and Nitric Oxide Study (The High-Ennd Study)

NCT00346970

Phase 4 Completed 32 enrolled Hannover Medical School
RandomizedParallel-groupSingle-blindTreatment

Summary

The aim of the present study is to characterize novel mechanisms whereby HDL may exert potent vasculoprotective effects independent of reverse cholesterol transport, in particular the effect of HDL on the regulation of the vascular NAD(P)H oxidase enzyme system, a major vascular source of superoxide, known to be important for endothelial dysfunction. In addition, the present study will characterize the effect of HDL on endothelial progenitor cell (EPC) mobilization, nitric oxide production and in vivo regenerative capacity.

Timeline

Start
2006-07
Primary completion
Completion
2007-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Niacin Small molecule 1500 mg

Indications